---
title: "Agentic-TimesFM-AKI: Dual LLM–Time Series System for Predicting Drug-Induced Acute Kidney Injury"
id: "medrxiv-3-agentic-timesfm-aki-a-dual-llm-time-series-framework-for-predicting-drug"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-3-agentic-timesfm-aki-a-dual-llm-time-series-framework-for-predicting-drug"
content_type: "clinical_feed_article"
specialty: "Critical Care"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.07.30.26359271v1?rss=1"
published_at: "2026-07-31T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Agentic-TimesFM-AKI: Dual LLM–Time Series System for Predicting Drug-Induced Acute Kidney Injury
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-3-agentic-timesfm-aki-a-dual-llm-time-series-framework-for-predicting-drug
- **Specialty:** [Critical Care](https://medichelpline.com/clinical-feed/critical-care.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.07.30.26359271v1?rss=1)
- **Published At:** 2026-07-31T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This preprint describes Agentic-TimesFM-AKI, a dual-model framework that pairs a **Large Language Model** (Gemma-4 Sentinel) with a zero-shot time-series forecaster (TimesFM) to forecast and explain risk of **Acute Kidney Injury (AKI)**, including drug-induced cases from agents like vancomycin and piperacillin–tazobactam. - The system was trained on a differentially private synthetic cohort (N=5,000 patient trajectories, ε=10) and evaluated on publicly available demo holdouts from **eICU** (N=200) and **MIMIC‑IV** (N=117). - On the internal eICU pilot, the framework reported high discrimination: Accuracy 0.970 (95% CI 0.945–0.990) and F1-Score 0.966, and generated temporally grounded natural-language alerts mapping physiological trajectories to explanations. - External validation on the MIMIC‑IV cohort showed marked performance degradation, indicating vulnerability to domain shift and differences in data formatting/schema. - The authors highlight structural formatting fragility when applying generative models to out-of-distribution electronic health records and emphasize interpretability via model-generated clinical reasoning. - All source code, the differentially private synthetic dataset and evaluation scripts are publicly available in the project repository and on the Hugging Face Model Hub; the paper notes the study is a reproducible pilot using demo datasets that do not require credentialing. - This work is presented as a preprint and has not undergone peer review; the authors report no competing interests and state ethical declarations were followed as reported in the source.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=IK753ST8p6ZmQ2d4ZIlf25Ktp7E2X_mZImWfFZ92G.M-1785547522.3309343-1.2.1.1-BDJ5jwB77SxFRhV7mBQGbXTb1kiO2o8kTuvLwVoYKps) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.07.30.26359271v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Agentic-TimesFM-AKI: A Dual LLM-Time Series Framework for Predicting Drug-Induced Acute Kidney Injury with Privacy-Preserving Synthetic Data [ View ORCID Profile](http://orcid.org/0000-0001-8906-3873)Gamal Esam AL-Sakkaf doi: https://doi.org/10.64898/2026.07.30.26359271 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Gamal Esam AL-Sakkaf Near East University * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Gamal%2BEsam%2BAL-Sakkaf%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=AL-Sakkaf%20GE&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AGamal%2BEsam%2BAL-Sakkaf%2B) * [ORCID record for Gamal Esam AL-Sakkaf](http://orcid.org/0000-0001-8906-3873 "Open in new tab") * For correspondence: 20205603@std.neu.edu.tr * [Abstract](https://www.medrxiv.org/content/10.64898/2026.07.30.26359271v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1269150/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.07.30.26359271v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1269150/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.07.30.26359271v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1269150/1) * [Supplementary material](https://www.medrxiv.org/content/10.64898/2026.07.30.26359271v1.supplementary-material)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_data/node:1269150/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.07.30.26359271v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1269150/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.07.30.26359271v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1269150/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Background: Acute kidney injury (AKI) is a severe complication in intensive care units, frequently exacerbated by synergistic nephrotoxicity from drugs such as Vancomycin and Piperacillin-Tazobactam. Traditional alert systems relying on static thresholds suffer from high false-positive rates and delayed detection. Methods: We developed Agentic-TimesFM-AKI, a dual-model architecture integrating a Large Language Model (Gemma-4 Sentinel) with a zero-shot time-series forecaster (TimesFM) to provide continuous, dynamic risk forecasting and transparent clinical reasoning. The system was trained on a synthetically generated cohort with differential privacy (ε=10) and evaluated on the publicly accessible eICU (N=200) and MIMIC-IV (N=117) Demo datasets. Results: In the internal eICU pilot evaluation, the framework achieved an Accuracy of 0.970 (95% CI: 0.945-0.990) and an F1-Score of 0.966, successfully mapping temporal physiological trajectories into intelligible natural language alerts. However, external validation on the MIMIC-IV cohort revealed severe performance degradation. Conclusions: While the dual-model framework provides highly accurate and interpretable AKI alerts on familiar schema cohorts, it suffers from structural formatting fragility and domain shift. This highlights critical vulnerabilities in applying generative models to out-of-distribution electronic health records. Keywords: Acute Kidney Injury, Large Language Models, Time-Series Forecasting, Electronic Health Records, Differential Privacy, Pharmacovigilance. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability The complete source code for the Agentic-TimesFM-AKI framework is publicly available at jamalesam93/Agentic-TimesFM-AKI. This includes the differentially private synthetic data generation pipeline, TimesFM LoRA fine-tuning scripts, Gemma-4 QLoRA training scripts, evaluation pipelines, and attention heatmap extraction utilities. Technical inquiries and requests for extended support may be directed at the corresponding author. The differentially private synthetic training cohort (N=5,000 patient trajectories, ε=10) and the eICU/MIMIC-IV holdout construction scripts are included in the repository and may be freely distributed, as the synthetic data contains no protected health information by design. Pre-trained model weights, including the merged Gemma-4-12B with LoRA adapters and quantized GGUF variants, are hosted on the Hugging Face Model Hub at QinEmPeRoR93/Agentic-TimesFM-AKI. This pilot study was evaluated on the publicly accessible eICU and MIMIC-IV demo datasets, which do not require the CITI training or institutional Data Use Agreements mandated for access to the full databases. Combined with the open-source differentially private synthetic training cohort, the entire evaluation pipeline is immediately reproducible by any researcher without credentialing barriers. Scaling to the complete eICU and MIMIC-IV databases requires separate credentialing through PhysioNet (https://physionet.org) under their respective Data Use Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC 4.0 International license](http://creativecommons.org/licenses/by-nc/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.07.30.26359271v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.07.29.26359169v1 "Relationships between increasing pre-load meal size, post-prandial acyl ghrelin, LEAP2, insulin, glucose, appetite, and food intake in adults without obesity")[Next ](https://www.medrxiv.org/content/10.64898/2026.07.29.26359283v1 "Interpretable Machine Learning to Improve Donor-Recipient Matching at Time of Heart Transplantation") Posted July 31, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.07.30.26359271v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/07/31/2026.07.30.26359271.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.07.30.26359271v1#p-5) [Supplementary Material ](https://www.medrxiv.org/content/10.64898/2026.07.30.26359271v1.supplementary-material) [ Data/Code](https://www.medrxiv.org/content/early/2026/07/31/2026.07.30.26359271.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Agentic-TimesFM-AKI: A Dual LLM-Time Series Framework for Predicting Drug-Induced Acute Kidney Injury with Privacy-Preserving Synthetic Data Gamal Esam AL-Sakkaf medRxiv 2026.07.30.26359271; doi: https://doi.org/10.64898/2026.07.30.26359271 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.07.30.26359271v1%26text%3DAgentic-TimesFM-AKI%253A%2520A%2520Dual%2520LLM-Time%2520Series%2520Framework%2520for%2520Predicting%2520Drug-Induced%2520Acute%2520Kidney%2520Injury%2520with%2520Privacy-Preserving%2520Synthetic%2520Data "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.07.30.26359271v1%26t%3DAgentic-TimesFM-AKI%253A%2520A%2520Dual%2520LLM-Time%2520Series%2520Framework%2520for%2520Predicting%2520Drug-Induced%2520Acute%2520Kidney%2520Injury%2520with%2520Privacy-Preserving%2520Synthetic%2520Data "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.07.30.26359271v1%26title%3DAgentic-TimesFM-AKI%253A%2520A%2520Dual%2520LLM-Time%2520Series%2520Framework%2520for%2520Predicting%2520Drug-Induced%2520Acute%2520Kidney%2520Injury%2520with%2520Privacy-Preserving%2520Synthetic%2520Data%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.07.30.26359271v1%26title%3DAgentic-TimesFM-AKI%253A%2520A%2520Dual%2520LLM-Time%2520Series%2520Framework%2520for%2520Predicting%2520Drug-Induced%2520Acute%2520Kidney%2520Injury%2520with%2520Privacy-Preserving%2520Synthetic%2520Data "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.07.30.26359271) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.07.30.26359271v1&count=horizontal&via=&text=Agentic-TimesFM-AKI%3A%20A%20Dual%20LLM-Time%20Series%20Framework%20for%20Predicting%20Drug-Induced%20Acute%20Kidney%20Injury%20with%20Privacy-Preserving%20Synthetic%20Data&counturl=www.medrxiv.org/content/10.64898/2026.07.30.26359271v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (594) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (887) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (322) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4676) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (465) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (402) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (630) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1592) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15638) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (32) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1175) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (6870) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (714) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1034) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (4843) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1411) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1697) * [Hematology](https://www.medrxiv.org/collection/hematology) (568) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1302) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16144) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1143) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (650) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (148) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (703) * [Neurology](https://www.medrxiv.org/collection/neurology) (7015) * [Nursing](https://www.medrxiv.org/collection/nursing) (357) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1056) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1206) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (987) * [Oncology](https://www.medrxiv.org/collection/oncology) (3508) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1014) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (381) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (432) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (453) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (135) * [Pathology](https://www.medrxiv.org/collection/pathology) (695) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1752) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (723) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (750) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5717) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9540) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2321) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1406) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1227) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (625) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (755) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (567) * [Surgery](https://www.medrxiv.org/collection/surgery) (750) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (105) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (296) * [Urology](https://www.medrxiv.org/collection/urology) (278) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the medRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy link)Copied! TRiP medRxiv partners with journals and review services to enable posting of peer reviews and editorial decisions related to preprints they are evaluating. Reviews are posted with the consent of the authors. TRiP reviews are part of a peer review pilot project in which participating organizations post peer reviews of manuscripts they are evaluating _There is no TRiP material for this paper._ Community Reviews medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Community reviews for this article: _There are no community reviews for this paper._ Automated Evaluations Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of these analyses is endorsed by medRxiv. Automated Evaluations: _There are no automated evaluations for this paper._ Blog/Media Links medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Video medRxiv partners with conferences and institutions to display recordings of talks and seminars related to preprints. These are posted with the consent of the authors. Video: _There are no videos for this paper._ Powered by [![Hypothes.is logo](https://connect.biorxiv.org/eval/hypothesis.png)](https://web.hypothes.is/) Powered by [![Altmetric logo](https://connect.biorxiv.org/eval/altmetric.png)](https://www.altmetric.com/) #
## Related Clinical Research

- [Endocrine Society Launches Center on Obesity and Unveils Scientific Statement on Obesity Medicines](https://medichelpline.com/clinical-feed/endocrine-news-1-experts-to-debut-society-s-center-on-obesity-and-new-scientific-statement.md)
- [Endocrine Society Launches Center on Obesity and New Scientific Statement on Obesity Medicines](https://medichelpline.com/clinical-feed/endocrine-news-0-new-offerings-demonstrate-the-endocrine-society-s-leadership-role-in-obesity.md)
- [Ultrasound‑pretreated enzymatic extraction of soluble dietary fiber from orange peel by-products](https://medichelpline.com/clinical-feed/plos-one-14-valorization-of-orange-peel-by-products-via-ultrasound-pretreated-enzymatic.md)
- [Waist circumference predicts mortality more than BMI in adults 65+: study findings](https://medichelpline.com/clinical-feed/medical-news-today-0-bmi-vs-waist-size-study-finds-belly-fat-matters-more-than-weight-for-death-risk.md)
- [Perinatal Serum FGF21 Changes and Postpartum Insulin Resistance in Gestational Diabetes](https://medichelpline.com/clinical-feed/pubmed-42669966.md) (DOI: 10.1111/jog.70480)

## Navigation
- [← Back to Critical Care Feed](https://medichelpline.com/clinical-feed/critical-care.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.